Clinical trial
Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes…
NCT00286494 · Takeda, Industry · Completed
Key facts
| NCT number | NCT00286494 |
|---|---|
| Title | Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus |
| Official title | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of SYR110322 (SYR-322) When Used in Combination With Pioglitazone in Subjects With Type 2 Diabetes Mellitus |
| Lead sponsor | Takeda, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Alogliptin and pioglitazone, Pioglitazone |
| Enrollment | 493 |
| Start date | Feb 1, 2006 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Feb 3, 2006 |
| Last update posted | Feb 3, 2012 |
| Countries | Argentina, Australia, Brazil, Czechia, Germany, Guatemala, Hungary, India, Mexico, Netherlands, New Zealand, Peru and 2 more |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: